National Institutes of Health: Nephrotic Syndrome trials
The registry lists 10 Nephrotic Syndrome studies with National Institutes of Health as lead sponsor. 4 are open to participants now and 1 have results posted.
Phase 2 7No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effects of Meal Macronutrients on Postprandial LipidsNot yet recruitingNCT07313787Phase 2
- Belimumab With Rituximab for Primary Membranous NephropathyRecruitingNCT03949855Phase 2
- Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyRecruitingNCT00977977Phase 2
- Immune System Related Kidney DiseaseRecruitingNCT00001979
- Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)CompletedNCT00001959Phase 2Results posted
- Glucocorticoid-induced Osteopenia in ChildrenCompletedNCT00289328
- Kidney Disease BiomarkersCompletedNCT00255398
- Once-A-Month Steroid Treatment for Patients With Focal Segmental GlomerulosclerosisCompletedNCT00004990Phase 2
- Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic SyndromeTerminatedNCT00004466Phase 2
- Drug Therapy in Lupus NephropathyCompletedNCT00001212Phase 2